Shock‐Like Sensations During Venlafaxine Withdrawal
The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Electric shock‐like sensations may occur after cessation of treatment with serotonin selective reuptake inhibitors but are reported in the literature only rarely with discontinuation of venlafaxine. Two patients experienced severe shock‐like sensations during venlafaxine withdrawal. For both patients symptoms occurred with lowering of the dosage and persisted for 5 days after complete discontinuation of the drug. These sensations may represent significant alteration of neuronal activity in the central nervous system.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Serotonin Reuptake Inhibitor Withdrawal
Coupland, N. J., Bell, C. J., & Potokar, J. P. (1996) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199610000-00003 · Cited by 303 · cited 2×
“Paresthesias may occur in up to 12% of patients stopping paroxetine.(19) An unexplained aspect of our two patients is that the addition of an SSRI, which theoretically would result in an increase of serotonin, did not alleviate withdrawal symptoms as it did for patients described by others.”
BackgroundWithdrawal reactions associated with venlafaxine
Parker, G., & Blennerhassett, J. (1998) · Australian & New Zealand Journal of Psychiatry · doi:10.3109/00048679809062742 · Cited by 45
Withdrawal and Rebound Symptoms Associated With Abrupt Discontinuation of Venlafaxine
Dallal, A., & Chouinard, G. (1998) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199808000-00017 · Cited by 32 · cited 1×
“Six of eight patients ending an 8week clinical trial required a gradual dosage reduction because they were experiencing withdrawal and rebound symptoms.(11) In a clinical trial of venlafaxine for obsessivecompulsive disorder,(12) four of nine patients developed a withdrawal syndrome at the end of a 12-week course of t…”
BackgroundVenlafaxine withdrawal reactions
Boyd, I. W. (1998) · Medical Journal of Australia · doi:10.5694/j.1326-5377.1998.tb140191.x · Cited by 14 · cited 2×
“In addition, 13 such reactions occurred between 1996 and 1998 in Australia.(10) Six of eight patients ending an 8week clinical trial required a gradual dosage reduction because they were experiencing withdrawal and rebound symptoms.”
Background
Cited by
Fava, G. A., Benasi, G., Lucente, M., Offidani, E., Cosci, F., & Guidi, J. (2018) · Psychotherapy and Psychosomatics · doi:10.1159/000491524 · Cited by 209
A review of the management of antidepressant discontinuation symptoms
Wilson, E., & Lader, M. (2015) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125315612334 · Cited by 103
When Discontinuing SSRI Antidepressants Is a Challenge: Management Tips
Jha, M. K., Rush, A. J., & Trivedi, M. H. (2018) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2018.18060692 · Cited by 73
Antidepressant Withdrawal and Rebound Phenomena
Henssler, J., Heinz, A., Brandt, L., & Bschor, T. (2019) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2019.0355 · Cited by 50
Metadata
- Authors
- Reeves, R. R., Mack, J. E., & Beddingfield, J. J.
- Venue
- Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
- Publisher
- Wiley
- Published
- 2003-05
- Volume
- 23
- Issue
- 5
- Pages
- 678-681
- ISSN
- 0277-0008 (ISSN-L)
- 1875-9114
- OpenAlex
- W2011587234
- Cited by
- 30
- References
- 4
- FWCI
- 1.75
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Shock‐Like Sensations During Venlafaxine Withdrawal. https://app.cochat.ai/papers/10.1592/phco.23.5.678.32198
- The paper
- Reeves, R. R., Mack, J. E., & Beddingfield, J. J. (2003). Shock‐Like Sensations During Venlafaxine Withdrawal. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. https://doi.org/10.1592/phco.23.5.678.32198
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.